Sp1062
DOES MY PATIENT WITH ACUTE DIVERTICULITIS NEED ANTIBIOTICS?
Date
May 21, 2024
Presenter
University of North Carolina
Tracks
Related Products
SURVODUTIDE REDUCES LIVER FAT CONTENT, TRANSAMINASES, AND FIBROSIS MARKERS WITH GOOD SAFETY PROFILE IN PEOPLE WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): AN INTERIM ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL
BACKGROUND: Survodutide is a novel glucagon receptor/glucagon-like peptide-1 receptor dual agonist under investigation for treatment in advanced liver disease associated with metabolic dysfunction-associated steatohepatitis (MASH), the most severe form of metabolic dysfunction-associated steatotic…
CHOLECYSTECTOMY IS A RISK FACTOR FOR MICROSCOPIC COLITIS: A NATIONWIDE POPULATION-BASED MATCHED CASE CONTROL STUDY.
BACKGROUND: Microscopic colitis (MC) is an inflammatory condition of the colon, characterized by watery, non-bloody, diarrhoea…
AGA GUIDELINE: INTESTINAL MICROBIOTA TRANSPLANTATION (IMT)
AGA guidelines are among the most rigorously evidence-based and trusted guidelines in the field of GI and hepatology…
